| Filed On | Filing |
|---|---|
| 26 Oct 2026 |
8-K: Entry into a Material Definitive Agreement
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission. |
| 15 Sep 2026 |
8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
Effective September 10, 2026, the Board of Directors of the Company approved a change in the Company’s fiscal year end from October 31 to June 30, effective for the fiscal year ending June 30, 2026. |
| 15 Sep 2026 |
8-K: Other Events
Company looks to broaden its Southeast presence to support healthcare providers navigating newly enacted state laws providing for certain stem cell and regenerative medicine therapies. |
| 01 Sep 2026 | 8-K: Other Events |
| 04 Aug 2026 | 8-K: Other Events |
| 21 Jul 2026 | 8-K: Other Events |
| 08 Jul 2026 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 01 Jul 2026 | 8-K: Other Events |
| 16 Jun 2026 | 8-K: Other Events |
| 12 Jun 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 09 Jun 2026 | 8-K: Other Events |
| 27 May 2026 | 8-K: Other Events |
| 12 May 2026 | 8-K: Other Events |
| 21 Apr 2026 | 8-K: Other Events |
| 09 Apr 2026 | 8-K: Other Events |
| 07 Apr 2026 | 8-K: Other Events |
| 31 Mar 2026 | 8-K: Other Events |
| 27 Mar 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 28 Jan 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 21 Jan 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
Loading...
